Investments in Other Entities (Tables)

12 Months Ended

Dec. 31, 2022

Equity Method Investments and Joint Ventures [Abstract]

Schedule of Equity Method Investments, Financial Statement Information

Investments in other entities – equity method consisted of the following (in thousands):

	December 31, 2021		Allocation of Income (Loss)		Funding reclassified to loan receivable		Funding		Entity Consolidated		Distribution		December 31, 2022
LaSalle Medical Associates – IPA Line of Business	$	3,034	$	4,775	$	(2,125)	$	—	$	—	$	—	$	5,684
Pacific Medical Imaging & Oncology Center, Inc.	1,719		159		—		—		—		—		1,878
531 W. College, LLC – related party	17,230		(619)		—		670		—		—		17,281
One MSO, LLC — related party	2,910		408		—		—		—		(600)		2,718
Tag-6 Medical Investment Group, LLC — related party	4,830		153		—		1,435		(6,418)		—		—
CAIPA MSO, LLC	11,992		746		—		—		—		—		12,738
	$	41,715	$	5,622	$	(2,125)	$	2,105	$	(6,418)	$	(600)	$	40,299

LMA’s unaudited summarized balance sheets at December 31, 2022 and 2021 and unaudited summarized statements of operations for the years ended December 31, 2022, 2021, and 2020 are as follows (in thousands):

Balance Sheets

	December 31, 2022 (unaudited)		December 31, 2021 (unaudited)
Assets
Cash and cash equivalents	$	15,671	$	6,619
Receivables, net	5,064		2,269
Prepaid assets	5,032		—
Loan receivable	2,250		2,250
Restricted cash	700		696
Total assets	$	28,717	$	11,834
Liabilities and stockholders’ deficit
Current liabilities	$	30,331	$	32,405
Stockholders’ deficit	(1,614)		(20,571)
Total liabilities and stockholders’ deficit	$	28,717	$	11,834

Statements of Operations

	Year Ended December 31, 2022 (unaudited)		Year Ended December 31, 2021 (unaudited)		Year Ended December 31, 2020 (unaudited)
Revenues	$	253,469	$	204,061	$	186,964
Expenses	239,884		220,132		185,724
Income (loss) from operations	13,585		(16,071)		1,240
Other (loss) income	(44)		—		8
Net income (loss)	$	13,541	$	(16,071)	$	1,248